Navigation Links
New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings
Date:12/7/2009

d with other medicines to treat partial-onset seizures in patients 17 years of age and older with epilepsy. Vimpat® is generally well-tolerated, but may not be for everyone. Patients should discuss with their doctor if Vimpat® is right for them.

The most common side effects with Vimpat® are dizziness, headache, nausea and double vision. Vimpat® may also cause problems with coordination and balance. Patients should not drive, operate machinery or do other dangerous activities until they know how Vimpat® affects them. Patients should not stop taking Vimpat® without first talking to their doctor. Stopping Vimpat® suddenly can cause serious problems. Vimpat® could make patients feel faint. Patients should tell their doctor if they have a heart condition or if they are taking other medicines that affect the heart. In rare cases, Vimpat® may cause reactions that could affect the heart, liver or kidney. The patient should contact their doctor immediately if they are tired, have jaundice (yellowing of skin or eyes), and have dark urine. Antiepileptic drugs, including Vimpat®, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Patients should call their healthcare provider right away if they have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that they have never had before or may be worse than before. To report SUSPECTED ADVERSE REACTIONS, contact UCB, Inc. at 1-866-822-0068 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see additional patient information including the Vimpat® Medication Guide at the end of the full prescribing information on http://www.vimpat.com
'/>"/>

SOURCE UCB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Gene Studies of Male-Female Differences Often Flawed
2. Two studies published in the Lancet
3. Study of Studies Finds No Risk to Children From Phthalates in Toys
4. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
5. Studies Prove Exercise Can Heal the Body Mind and Soul
6. Studies Shed New Light on Breast Cancer, Treatment
7. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , Resistance to artemisinin, the main drug to ... among the Plasmodium falciparum ( P. ... is likely caused by a genetic mutation in ... combination therapyas opposed to a standard three-day coursehas ... according to findings published today in the ...
(Date:7/30/2014)... July 30, 2014 Volunteers from the ... counter drug abuse this summer with massive distribution of ... You can find these volunteers on Strøget, the famous ... alike for its shopping and its ambiance, some quarter ... a typical summer day. , These activities are ...
(Date:7/30/2014)... Visitors to our region recognize how special ... its protection. Bob Kiesendahl, one of the owners of ... Highlands Conservancy for donations collected through participation in the ... up fast, as visitors welcome the opportunity to invest ... , The Kiesendahl family has owned Woodloch Resort for ...
(Date:7/30/2014)... Orange, NJ. July 30, 2014. A new network of ... NIH Stroke Trials Network (NIH StrokeNet) is working ... the U.S. Despite advances of the last two ... year, stroke causes death or disability for 795,000 Americans. ... aging of the population. , To accelerate the ...
(Date:7/30/2014)... 30, 2014 LTC Consumer, an independent, free ... care insurance, features an Instant Quote tool on its website, ... of LTC Consumer. Quotes are free and unlimited. , The ... only seven areas – including age, gender, and state of ... seconds (you don’t need to enter any contact information to ...
Breaking Medicine News(10 mins):Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2
... School of Engineering and Applied Science have taken a ... successfully using the bacterium Escherichia coli to ... polyketides, which include important antibiotic and anticancer drugs. ... potent chemical compounds produced by living organisms; many are ...
... 2008 The Women,s Heart Health Initiative at the ... a new fellowship dedicated to gender-specific research that will ... in women. The announcement will take place during a ... "Women face unique challenges to successful diagnosis and treatment ...
... offered the perfect job. The not-so-good news it,s ... people with diseases like HIV, or those who are simply ... a medical exam to qualify for a job can be ... brings excellent news. , Medical exams are often not an ...
... Women with deficiency at time of delivery had almost ... 22 (HealthDay News) -- Vitamin D deficiency greatly increases ... U.S. researchers report. , During the two-year study, Boston ... examined the relationship between vitamin D levels in pregnant ...
... oncology researcher Dr. Daniel Von Hoff, a member ... an in-depth look at the "lost opportunity" in ... biotechnology companies use the phase I trial to ... Hoff advocates that it can also provide valuable ...
... from overweight and obesity. This is the result of a ... Elisabeth Weber and her coauthors present the results in the ... Arztbl Int 2008; 105 [51-52]: 883-9). The doctors recorded ... children, but also their mother tongue. Their parents had to ...
Cached Medicine News:Health News:E. coli engineered to produce important class of antibiotic, anti-cancer drugs 2Health News:A simple questionnaire to replace a doctor's exam 2Health News:Renowned Cancer Researcher Dan Von Hoff, M.D. Advocates for 'The Lost Opportunity in Phase I Oncology Trials' 2Health News:Renowned Cancer Researcher Dan Von Hoff, M.D. Advocates for 'The Lost Opportunity in Phase I Oncology Trials' 3Health News:Renowned Cancer Researcher Dan Von Hoff, M.D. Advocates for 'The Lost Opportunity in Phase I Oncology Trials' 4
(Date:7/30/2014)... /PRNewswire-iReach/ -- This is a professional and in-depth ... (CAS 9041-08-1) & calcium (CAS 37270-89-6) industry. The ... sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) including ... then explores global and China,s top manufacturers of ... listing their product specification, capacity, production value, cost, ...
(Date:7/30/2014)... , July 30, 2014   Bluegrass Vascular ... on innovating lifesaving devices and methods for vascular ... in Series A financing, which was led by ... the deal will allow Bluegrass Vascular to obtain ... System, enhance manufacturing capabilities, and proceed with US ...
(Date:7/30/2014)... , July 30, 2014 ... CUDA programming expertise to big data, aerospace and ... eInfochips, a leading engineering R&D services company, ... develop NVIDIA GPU-powered solutions for aerospace and ... computing (HPC), industrial , and ...
Breaking Medicine Technology:Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2eInfochips to Develop NVIDIA GPU-powered Solutions for Aerospace and Defense, Medical Imaging, HPC and Visual Computing 2
... Dec. 5, 2011   New product launches are continually ... critical for organizations to balance the dueling goals of containing ... executives face is determining how much to invest, and how ... budget for primary care launch is spent before ...
... 5, 2011 Technology is revolutionizing healthcare — making ... lowering the cost of care. AT&T ,s* new ... — is designed to do just that. The 2011 ... awarded to AT&T for its approach to mHealth, recognizing ...
Cached Medicine Technology:Launch Spend Insights: Companies Now Invest More in Launch Year Than in Previous 3 Ramp-Up Years Combined 2Frost and Sullivan Recognizes AT&T's Innovative mHealth Strategy 2Frost and Sullivan Recognizes AT&T's Innovative mHealth Strategy 3Frost and Sullivan Recognizes AT&T's Innovative mHealth Strategy 4
... a plastic device that fits over a standard ... a minimum amount of reagent. , , ... between the coverplate and slide. The liquid ... is dispensed into the well. Its pressure ...
ISI Micro Brushes are available in a variety of French diameters. Made with stainless steel handles and nylon bristles, the ISI Micro Brushes will last through countless cleanings....
... ISI offers instrument cleaning brushes ... diameters and composition. The long, ... cannulas and tubing. The smallest ... micros. The brass and stainless ...
... Nest is the wall organizer with a complete ... of sizes and diameters. Made of tough, durable ... Brush Nest is the ultimate organizer. , The ... in a variety of lengths, diameters and composition.,The ...
Medicine Products: